These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15385671)

  • 1. Forgotten but not gone.
    Itskowitz MS
    N Engl J Med; 2004 Sep; 351(13):1361; author reply 1361. PubMed ID: 15385671
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of latent tuberculosis infection.
    Lepage P
    N Engl J Med; 2003 Mar; 348(13):1292-3; author reply 1292-3. PubMed ID: 12661577
    [No Abstract]   [Full Text] [Related]  

  • 3. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completing tuberculosis prophylaxis in jail: targeting treatment and a comparison of rifampin/pyrazinamide with isoniazid regimens.
    Lambert LA; Ijaz K; Navin TR
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):230; author reply 230-1. PubMed ID: 15732748
    [No Abstract]   [Full Text] [Related]  

  • 5. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
    Moulding T
    Int J Tuberc Lung Dis; 2000 May; 4(5):485-6. PubMed ID: 10815744
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoniazid treatment of children: can genetics help guide treatment?
    Cranswick N; Mulholland K
    Arch Dis Child; 2005 Jun; 90(6):551-3. PubMed ID: 15908610
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of plasma levels of isoniazid for dose adjustment in the hemodialysis patients.
    El Kabbaj D; Aatif M; Moussa LA; Khassouani CE; Oualim Z
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):666-7. PubMed ID: 19587514
    [No Abstract]   [Full Text] [Related]  

  • 8. [HPLC study of blood isoniazid in patients with tuberculosis in Tunisia: significance and therapeutic results].
    Barhoumi C; Masmoudi AS; Gritli N; Hamza M; Nsiri B; Amor A; Mechghoul S; Belhadj O
    Tunis Med; 1995 Oct; 73(10):379-84. PubMed ID: 9506162
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of once-weekly therapy for tuberculosis using isoniazid plus rifamycins in the mouse aerosol infection model.
    Brooks JV; Orme IM
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3047-8. PubMed ID: 9797254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of antibacterial preparations incorporated into liposomes in the treatment of experimental tuberculosis].
    Kurunov IuN; Nikolin VP; Kaledin VI; Matienko NA; Budker VG
    Probl Tuberk; 1982 Oct; (10):54-8. PubMed ID: 7178105
    [No Abstract]   [Full Text] [Related]  

  • 11. In closely monitored patients, adherence in the first month predicts completion of therapy for latent tuberculosis infection.
    Menzies D; Dion MJ; Francis D; Parisien I; Rocher I; Mannix S; Schwartzman K
    Int J Tuberc Lung Dis; 2005 Dec; 9(12):1343-8. PubMed ID: 16466056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical and pharmacokinetic features of lymphotropic therapy in patients with new-onset pulmonary tuberculosis].
    Priakhina VN; Kolpakov MA; Kolpakov AR; Zyrianova TV; Mokhina OG
    Probl Tuberk Bolezn Legk; 2005; (6):55-8. PubMed ID: 16078725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy in newly detected tuberculosis. The methodologic approach of the Expert Committee on Pulmonary Diseases and Tuberculosis].
    Plucne Bolesti; 1986; 38(3-4):289-92. PubMed ID: 3588754
    [No Abstract]   [Full Text] [Related]  

  • 14. The timing of directly observed therapy--a need for caution.
    Falade AG; Osinusi K; Tongo OO
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):640-1. PubMed ID: 10423231
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis chemotherapy, a review of current treatment regimens.
    Teo SK
    Singapore Med J; 1982 Feb; 23(1):55-60. PubMed ID: 7051331
    [No Abstract]   [Full Text] [Related]  

  • 16. Patients with drug-resistant tuberculosis who were treated with standardized short-course chemotherapy.
    Munsiff SS; Ahuja SD
    Clin Infect Dis; 2005 May; 40(10):1549-50. PubMed ID: 15844084
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-tuberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the International Union against Tuberculosis and Lung Disease.
    Girling DJ; Caulet P; Pamra SP; Pilheu JA
    Indian J Chest Dis Allied Sci; 1988; 30(4):296-304. PubMed ID: 3076583
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy in tuberculosis].
    Somoskövi A; Lantos A
    Orv Hetil; 2004 Apr; 145(16):871-3. PubMed ID: 15156693
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should isoniazid and clofazimine be used to treat multidrug-resistant tuberculosis?
    Seung KJ
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):231-2; author reply 232. PubMed ID: 15732749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.